Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-05-15
著者
-
OHNO Ryuzo
Aichi Cancer Center
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Shimoda Kazuya
九州大学 第1内科
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
NAKAO Shinji
Kanazawa University Hospital
-
AMAGASAKI Taro
Novartis Pharma Japan
-
NAITO Kensuke
The Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
TAKESHITA Akihiro
Department of Medicine III, Hamamatsu University School of Medicine
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Shinagawa Katsuji
岡山大学 第2内科
-
Naito Kensuke
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Shinjo Kaori
浜松医科大学 内科学第3
-
NAITO Kensuke
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
KOBAYASHI Miki
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
SAHARA Naohi
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
SHIGENO Kazuyuki
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
NAKAMURA Satoki
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
SHINJO Kaori
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
TOBITA Tadasu
Department of Hematology, Yaizu City Hospital
-
OHNISHI Kazunori
Division of Hematology, Department of Medicine III, Hamamatsu University School of Medicine
-
Sahara Naohi
浜松医科大学 内科学第3
-
Nakamura Satoki
県西部浜松医療センター 血液科
-
Nakamura Satoki
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tomida Akihiro
癌研究会癌化学療法センター
-
Kobayashi Miki
Department Of Hematology Hamamatsu Medical Center
-
Shirafuji Naoki
Department Of Hematology Kanazawa University
-
Shimoda Kazuya
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
Nakao Shinji
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tobita Tadasu
The Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Nakao Shinji
Third Department Of Medicine Kanazawa University
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Shirafuji Naoki
Department Of Hematology/oncology Teikyo University School Of Medicine
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Sahara Naohi
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Naito Kensuke
Department Of Hematology Hamamatsu Medical Center
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- G-CSF does not Stimulate Leukemic Stem Cells in Vivo
- Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura With an IgG-Type Inhibitor to von Willebrand Factor-Cleaving Protease Activity
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF
- Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Glanzmann Thrombasthenia with Acute Myeloid Leukemia Successfully Treated by Bone Marrow Transplantation
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Successful Engraftment of Allogeneic Peripheral Blood Stem Cell Transplant After Nonmyeloablative Preparative Regimen With Cytarabine and Cyclophosphamide: Report of 2 Cases
- Molecular characterization of total kininogen deficiency in Japanese patients
- Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation
- Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
- Successful Treatment of Progressive NK Cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions
- Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
- Severe Bleeding Tendency Caused by Leukemic Infiltration and Destruction of Vascular Walls in Chronic Neutrophilic Leukemia
- Transient Factor VIII Inhibitor in a Hemophilia Patient After Staphylococcal Septic Shock Syndrome
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenstrom's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
- Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
- Myositis as a Manifestation of Chronic Graft-Versus-Host Disease
- Allogeneic Peripheral Blood Stem Cell Transplantation for the Treatment of Refractory Follicular Lymphoma
- Treatment of Refractory Metastatic Choriocarcinoma with Tandem High-Dose Chemotherapy Supported by Peripheral Blood Stem Cell Transplantation : A Case Report
- Graft rejection and recovery of host-derived hematopoiesis after allogeneic bone marrow transplantation : relation to conditioning with high does etoposide and total body irradiation
- Physical and functional interactions between ZIP kinase and UbcH5
- Pulmonary infiltration with eosinophilia syndrome complicated with non-Hodgkin's lymphoma of B cell lineage
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Metastasis to the Iris in Squamous Cell Lung Cancer
- High-Dose Etoposide Treatment for CNS Involvement in a Patient with Primary Non-Hodgkin's Lymphoma of the Breast
- An RNA biding protein, Y14 interacts with and modulates STAT3 activation
- The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation
- Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor Regulates Enhanced Activation of Signal Transducer and Activator of Transcription 3 by Epstein-Barr Virus-Derived Epstein-Barr Nuclear Antigen 2
- STAP-2 Negatively Regulates both Canonical and Noncanonical NF-κB Activation Induced by Epstein-Barr Virus-Derived Latent Membrane Protein 1
- The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction
- Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-β signaling
- KAP1 regulates type I interferon/STAT1-mediated IRF-1 gene expression
- LIF- and IL-6-Induced Acetylation of STAT3 at Lys-685 through PI3K/Akt Activation.
- DUSP22/LMW-DSP2 regulates estrogen receptor-α-mediated signaling through dephosphorylation of Ser-118
- Phosphorylation of threonine-265 in Zipper-interacting protein kinase plays an important role in its activity and is induced by IL-6 family cytokines
- HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
- Epstein-Barr virus-derived EBNA2 regulates STAT3 activation
- The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals
- Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
- MLL Gene Rearrangement in t(9;11) Acute Myelogenous Leukemia With Minimal Myeloid Differentiation (FAB Subtype M0)
- Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice
- Physical and functional interactions between Daxx and TSG101.
- A Novel Mutation in the Juxtamembrane Intracellular Sequence of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Gene in a Patient with Severe Congenital Neutropenia Augments G-CSF Proliferation Activity but Not through the MAP Kinase Cascade
- In Vitro Study of Deoxymethylspergualin on Functions of Lymphocytes and Bone Marrow Cells From Healthy Volunteers
- A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
- Physical and functional interactions between STAP-2/BKS and STAT5.
- Daxx enhances Fas-mediated apoptosis in a murine pro-B cell line, BAF3.
- Physical and functional interactions between STAT3 and ZIP kinase.
- Zipper-interacting protein kinase modulates canonical Wnt/beta-catenin signaling through interacting with Nemo-like kinase and T-cell factor 4
- Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-β signaling.
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- How High Can We Increase Complete Remission Rate in Adult Acute Myeloid Leukemia?
- 4 Activity of the Science Council of Japan Aiming for Tobacco-free Society in Japan(The 6th Anti-Smoking Promotion Seminar, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Treatment of chronic myeloid leukemia with imatinib mesylate
- Leukemia inhibitory factor-induced phosphorylation of STAP-2 on tyrosine-250 is involved in its STAT3-enhancing activity.
- Nuclear retention of STAT3 through the coiled-coil domain regulates its activity.
- Regulation of transforming growth factor-β signaling by protein inhibitor of activated STAT, PIASy through Smad3.
- The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
- Involvement of NF-kB in TGF-β-mediated suppression of IL-4 signaling.
- Systemic Vasculitis Associated with α1-antitrypsin Deficiency
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Functional involvement of Daxx in gp130-medicated cell growth and survival in BaF3 cells
- Clinical Features and Outcomes of 35 Disseminated Intravascular Coagulation Cases Treated with Recombinant Human Soluble Thrombomodulin at a Single Institution
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study